How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions

Despite significant advances in therapeutic possibilities for the treatment of inflammatory bowel disease (IBD) in recent years, there is still a big room for improvement. In particular, biological treatment can induce not only clinical remission but also mucosal healing of the gastrointestinal trac...

Descripción completa

Detalles Bibliográficos
Autores principales: Eder, Piotr, Zielińska, Aleksandra, Karczewski, Jacek, Dobrowolska, Agnieszka, Słomski, Ryszard, Souto, Eliana B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554748/
https://www.ncbi.nlm.nih.gov/pubmed/34715852
http://dx.doi.org/10.1186/s12951-021-01090-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554748/
https://www.ncbi.nlm.nih.gov/pubmed/34715852
http://dx.doi.org/10.1186/s12951-021-01090-1

Ejemplares similares